FC vs NBIX · rev $267.1M vs P/E 45, rev $2.36B
Franklin Covey Company (FC) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Franklin Covey Company (FC) is a education & training services company listed on NYSE.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FC revenue for 2025-08-31 was $267.1M. Net income was $3.1M. Revenue was down 7.0% from 2024-08-31 to 2025-08-31. FC currently screens at market cap $264.0M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FC currently screens at market cap $264.0M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FC and NBIX stock pages for the full models.
Not investment advice.